Since the discovery of the hepatitis C virus in 1989, there have been major breakthroughs in understanding the virology and epidemiology of hepatitis C infection, and management of hepatitis C-related disease. Globally, treatment uptake is extremely low, responses to treatment remain sub-optimal, and the burden of disease continues to expand. Even in Australia, where implementation of harm reduction strategies for people who inject drugs has long been a public-health priority, and hepatitis C therapy is available through a subsidised treatment program, transmission continues at a high level and the number of people with advanced liver disease continues to rise. The challenges for control of the hepatitis C epidemic are clearly immense.
|Title of host publication||Hepatitis C - An Expanding Perspective|
|Editors||Gregory Dore, Meredith Temple-Smith, Andrew Lloyd|
|Place of Publication||Australia|
|Pages||27 - 42|
|Number of pages||16|
|Publication status||Published - 2009|